These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19222505)

  • 1. Should heart, lung, and liver transplant recipients receive immunosuppression induction for kidney transplantation?
    Ranney DN; Englesbe MJ; Muhammad W; Al-Holou SN; Park JM; Pelletier SJ; Punch JD; Lynch RJ
    Clin Transplant; 2010; 24(1):67-72. PubMed ID: 19222505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database.
    Bunnapradist S; Chung P; Peng A; Hong A; Chung P; Lee B; Fukami S; Takemoto SK; Singh AK
    Transplantation; 2006 Sep; 82(5):612-8. PubMed ID: 16969282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
    Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry.
    Hachem RR; Edwards LB; Yusen RD; Chakinala MM; Alexander Patterson G; Trulock EP
    Clin Transplant; 2008; 22(5):603-8. PubMed ID: 18435784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daclizumab is associated with decreased rejection and improved patient survival in renal transplant recipients.
    Morris JA; Hanson JE; Steffen BJ; Chu AH; Chi-Burris KS; Gotz VP; Gordon RD
    Clin Transplant; 2005 Jun; 19(3):340-5. PubMed ID: 15877795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards minimizing immunosuppression in pediatric liver transplant recipients.
    Turmelle YP; Nadler ML; Anderson CD; Doyle MB; Lowell JA; Shepherd RW
    Pediatr Transplant; 2009 Aug; 13(5):553-9. PubMed ID: 19067920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of intensive initial immunosuppression protocol in pediatric deceased donor renal transplantation.
    Olaitan OK; Zimmermann JA; Shields WP; Rodriguez-Navas G; Awan A; Mohan P; Little DM; Hickey DP
    Pediatr Transplant; 2010 Feb; 14(1):87-92. PubMed ID: 19309452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
    Freise CE; Kang SM; Feng S; Posselt A; Hirose K; Hirose R; Stock P
    Transplant Proc; 2004 May; 36(4):1067-8. PubMed ID: 15194370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of chronic allograft nephropathy and subsequent modifications of immunosuppressive therapy on late graft outcomes in renal transplantation.
    Montagnino G; Banfi G; Campise MR; Passerini P; Aroldi A; Cesana BM; Ponticelli C
    Nephrol Dial Transplant; 2004 Oct; 19(10):2622-9. PubMed ID: 15316096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal transplantation following previous heart, liver, and lung transplantation: an 8-year single-center experience.
    Coopersmith CM; Brennan DC; Miller B; Wang C; Hmiel P; Shenoy S; Ramachandran V; Jendrisak MD; Ceriotti CS; Mohanakumar T; Lowell JA
    Surgery; 2001 Sep; 130(3):457-62. PubMed ID: 11562670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of everolimus as a rescue immunosuppressive therapy in liver transplant patients with neoplasms.
    Gomez-Camarero J; Salcedo M; Rincon D; Lo Iacono O; Ripoll C; Hernando A; Sanz C; Clemente G; Bañares R
    Transplantation; 2007 Sep; 84(6):786-91. PubMed ID: 17893613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of HCV infection on first cadaveric renal transplantation, a single center experience.
    Lin HH; Huang CC; Huang JY; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH
    Clin Transplant; 2004 Jun; 18(3):261-6. PubMed ID: 15142046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
    J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM
    Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac operations in solid-organ transplant recipients.
    Mitruka SN; Griffith BP; Kormos RL; Hattler BG; Pigula FA; Shapiro R; Fung JJ; Pham SM
    Ann Thorac Surg; 1997 Nov; 64(5):1270-8. PubMed ID: 9386690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.